This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Banerji, S. et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486, 405–409 (2012).
Bauer, K. R., Brown, M., Cress, R. D., Parise, C. A. & Caggiano, V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 109, 1721–1728 (2007).
Pal, S. K., Childs, B. H. & Pegram, M. Triple negative breast cancer: unmet medical needs. Breast Cancer Res. Treat. 125, 627–636 (2011).
Craig, D. W. et al. Genome and transcriptome sequencing in prospective refractory metastatic triple negative breast cancer uncovers therapeutic vulnerabilities. Mol. Cancer Ther. 12, 104–116 (2013).
Robinson, D. R. et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nature Med. 17, 1646–1651 (2011).
Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214–220 (2011).
Perner, S. et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res. 66, 8337–8341 (2006).
Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644–648 (2005).
Sboner, A. et al. FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. Genome Biol. 11, R104 (2010).
Pflueger, D. et al. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res. 21, 56–67 (2011).
Mosquera, J. M. et al. Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes Chromosom. Cancer 52, 538–550 (2013).
Mosquera, J. M. et al. Novel miR143-NOTCH fusions in benign and malignant glomus tumors. Genes Chromosom. Cancer 52, 1075–1087 (2013).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Author information
Authors and Affiliations
Contributions
J.M.M. performed experimental work and wrote the paper; S.V. performed experimental work and wrote the paper; C.P., T.Y.M., J.J.Y., Z.V. and H.M. performed experimental work; A.S. performed data analysis; S.J.S. performed project planning and revised the paper; M.A.R. designed research, performed project planning and revised the paper.
Corresponding authors
Ethics declarations
Competing interests
Declared none.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Mosquera, JM., Varma, S., Pauli, C. et al. MAGI3–AKT3 fusion in breast cancer amended. Nature 520, E11–E12 (2015). https://doi.org/10.1038/nature14265
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature14265
This article is cited by
-
Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
Molecular Biomedicine (2022)
-
Mechanics of molecular beacons for mRNA detecting
Acta Mechanica Sinica (2021)
-
Distinct functions of AKT isoforms in breast cancer: a comprehensive review
Cell Communication and Signaling (2019)
-
Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants
npj Breast Cancer (2016)
-
Cancer: hunting rare somatic mutations
Nature Methods (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.